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Defects in an intracellular chloride channel CLC-5 cause Dent’s disease, an inherited kidney stone disorder. Using a collecting duct
model, mIMCD-3 cells, we show expression of dimeric mCLC-5. Transient transfection of antisense CLC-5 reduces CLC-5 protein
expression. Binding of both calcium phosphate (hydroxyapatite) and calcium oxalate monohydrate (COM) crystals overlaid onto mIMCD-3
cultures was affected by altered CLC-5 expression. Calcium phosphate crystal agglomerations (>10 Am) were minimal in control (9%) and
sense (13%) CLC-5-transfected cells, compared to 66% of antisense CLC-5-transfected cells (P< 0.001). Small calcium phosphate crystals
( < 10 Am) were found associated with 45% of sense CLC-5-treated cells, of which the majority (11/14 cells) appeared to be internalised
within the cell. Calcium oxalate agglomerations (>10 Am) were also largely absent for controls or sense mCLC-5 transfectants (11% and
9% of cells, respectively) with COM crystal agglomerates predominating in antisense CLC-5 transfectants (66%, P < 0.0001). We conclude
that collecting duct cells with reduced CLC-5 expression lead to a tendency to form calcium crystal agglomeration, which may help explain
the nephrocalcinosis and nephrolithiasis seen in Dent’s disease.
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1. Introduction ultimately leading to nephrolithiasis and physical blockadeConcentration of urine occurs along the collecting duct
resulting in supersaturation of the tubular luminal fluid with
respect to calcium and anions, including phosphate and
oxalate. This leads to calcium phosphate and calcium oxalate
microcrystal formation [1], the retention of which is required
for stone formation [2]. Both calcium phosphate and calcium
oxalate crystals are injurious to renal epithelial cells [3,4].
Studies in a number of renal epithelial cell lines show that
calcium phosphate (hydroxyapatite) [5,6] and calcium oxa-
late monohydrate (COM) crystals [6,7] may bind to the
apical cell surface. Retention of the crystal at the cell surface
in vivo is likely to act as a nucleus for further crystal growth,0925-4439/$ - see front matter D 2004 Elsevier B.V. All rights reserved.
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E-mail address: j.a.sayer@ncl.ac.uk (J.A. Sayer).of the duct [1]. To protect against this, urine flow will flush
the epithelial surface, therefore limiting crystal attachment.
In addition, internalisation of calcium phosphate (hydroxy-
apatite) and COM crystals via endocytosis is known to occur
in cultured renal epithelial cells [8,9] and is a postulated
physiological clearance mechanism [10].
Dent’s disease is a complex X-linked disorder resulting
from inactivating mutations in the CLCN5 gene encoding an
intracellular chloride channel CLC-5 [11]. Dent’s disease is
characterised in males by low molecular weight proteinuria,
phosphaturia and aminoaciduria with hypercalciuria, neph-
rocalcinosis and nephrolithiasis, leading to progressive renal
failure [12,13]. Both calcium phosphate and calcium oxalate
stones are commonly seen in male patients [13]. CLC-5 is a
member of the CLC-family of chloride channels, which act
as voltage-gated anion channels and have a conserved
structure [14], with the ability to form homodimers [15].
CLC-5 mRNA and protein are expressed in multiple nephron
segments including the proximal tubule, medullary thick
ascending limb and collecting duct cells [16–19].
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has been established, where CLC-5 colocalises with acidic
endocytic compartments and facilitates receptor-mediated
endocytosis of filtered proteins [16,20]. In mouse CLC-5
knockout models, the endosomal trafficking defect within
proximal tubular epithelia [14,21,22] leads to secondary
changes in PTH and 1,25-dihydroxyvitamin D3. PTH stim-
ulation of apical receptors due to escape from endocytosis
leads to down-regulation of apical membrane Na+-Pi cotrans-
porters and leads to phosphaturia, whilst PTH-mediated a-
hydroxylation may lead to elevated 1,25-dihydroxyvitamin
D3 (provided adequate 25-hydroxyvitamin D3 is available)
and contribute to the hypercalciuria [14,21]. Indeed, hyper-
calciuria and microscopic nephrocalcinosis are evident in one
of the murine models of Dent’s disease [22]. Despite this
extensive knowledge of the pathophysiology, it remains
uncertain whether such changes may account fully for the
renal phenotype, especially stone formation. Beyond the
proximal tubule, the role of CLC-5 in the thick ascending
limb and collecting ducts is still controversial.
We have previously shown that using antisense CLC-5
transfection we could cause an arrest of endocytosis in
collecting duct cells [10]. In addition, formation of calcium
oxalate crystals in situ by a vapour diffusion technique
resulted in crystal agglomerates forming on antisense CLC-
5-treated cells [10]. It is known that whilst most renal
stones contain calcium oxalate as the major component
[23], calcium phosphate is frequently found at the core of
the stone [24,25], suggesting that calcium phosphate crystal
formation may be the initiating event in calcium oxalate
formation. Indeed, calcium phosphate was found to be
present as the initial plaque lesion in stone-forming patients
with either idiopathic hypercalciuric patients or hyperox-
aluria secondary to intestinal bypass [26]. As Dent’s disease
patients present with both species of stone the cell surface
crystal handling of both calcium phosphate and calcium
oxalate was therefore investigated in our experiments. The
purpose therefore of this work was to determine whether an
endosomal defect, secondary to knockdown of CLC-5,
might impact on calcium phosphate and calcium oxalate
crystal handling in a collecting duct cell model (mIMCD-3
cells [27]). These well-characterised epithelial cells [28]
endogenously express CLC-5 [29], which colocalises intra-
cellularly with acidic endosomal compartments [29].
mIMCD-3 cells are also endocytically active [10] and
readily bind calcium crystals [10].2. Materials and methods
2.1. Tissue culture
mIMCD-3 cells were provided by Dr. S. Gullans [27] and
were cultured in 50:50 v/v HAMS-F12/DMEM with 2 g/
l glucose, 10% v/v FCS and 2 mM L-glutamine as previ-
ously described [29].2.2. Molecular reagents
Sense CLC-5 construct (full-length murine CLC-5),
antisense CLC-5 construct (full-length reverse orientation
mCLC-5), and mCLC-5-GFP (mCLC-5 with a GFP fusion
protein) were prepared as previously described [29].
2.3. Western blotting
mIMCD-3 cultures were incubated in protein lysis buffer
(2% Nonidet P-40, 0.2% SDS, 1 mM DTT in PBS, protease
inhibitor mix (Complete Mini, Roche Diagnostics Ltd.)).
The lysate was centrifuged (1000 g, 10 min) treated with
NuPAGE reducing agent, (containing 0.5 M DTT (Invitro-
gen Life Technologies)) and heated for 10 min at 70 jC.
More stringent reducing conditions (h-mercaptoethanol),
heating and sonication were used in parallel experiments.
Protein concentrations were determined using the Bradford
method [30].
After SDS-PAGE (4–12% Bis–Tris) proteins were trans-
ferred to PDVF membranes. Blots were blocked in Tris-
buffered saline containing 0.1% Tween (TBS-T) and 5%
milk powder. Blots were incubated with rabbit anti-CLC-5
antibody PEP5A1 (directed against peptide CKSRD
RDRHREITNKS-amide) diluted (1:500) in blocking solu-
tion at 37 jC for 1 h then at 4 jC for 24 h. For peptide/
antigen competition experiments, the peptide CKSRDRDR
HREITNKS-amide was pre-incubated in excess (100 Ag)
with primary antibody. The mixture was then centrifuged
(10,000 g, 1 min) and the supernatant used in parallel to
primary antibody. Anti rabbit-HRP conjugate (1:20,000 in
TBS-T) was used for secondary detection. Reacting proteins
were detected using an ECL plus system (Amersham Phar-
macia Biotech) and photographic film (hyperfilm ECL,
Amersham Pharmacia Biotech). Membranes were stripped
and re-probed using primary antibody rabbit anti-actin anti-
body (Sigma) and secondarily detected using anti-rabbit
HRP conjugate (as above). Band densitometry was per-
formed on digitized gel images by Alpha Image software.
2.4. Transient transfection
mIMCD-3 cells were transfected using either Effectene
(Qiagen) or Lipofectamine 2000 (Life Technologies)
reagents. For Western blot analysis, 75 cm2 flasks of sub-
confluent cells were transiently transfected with sense or
antisense CLC-5 plasmid DNA and protein lysate harvested
48 h post transfection. For localisation experiments, cells
were seeded onto 13 mm glass coverslips (30,000/cm2) the
day prior to transfection. mCLC-5-GFP was transiently
transfected 24 h prior to counter staining.
2.5. Calcium phosphate and COM crystal experiments
Calcium phosphate (hydroxyapatite) crystals were
formed from a solution of 2.5 M CaCl2, 500 Al of 1/10
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Fig. 1. Western blot analysis of CLC-5 expression using PEP5A1 anti-
CLC-5 specific antibody. (A) In the upper panels, whole mouse kidney
homogenate (lanes 1 and 3) and mIMCD-3 cell protein lysate (lanes 2 and
4) were probed with PEP5A1 anti-CLC-5 antibody (lanes 1 and 2) and
PEP5A1 antibody preabsorbed with CKSRDRDRHREITNKS-amide (lanes
3 and 4). In the lower panels, the membrane was stripped and reprobed with
anti-actin antibody confirming protein loading. (B) CLC-5 protein
expression in mIMCD-3 cultures after no treatment (control) or following
transient transfection with sense or antisense CLC-5 plasmid DNA.
Stripping and reprobing membranes with anti-actin (42 kDa) demonstrates
equal protein loading.
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ml of 2 HEPES solution (140 mM NaCl, 1.5 mM
Na2HPO4, 50 mM HEPES, pH 7.05 at 23 jC). Media was
aspirated from sub-confluent cells transiently transfected (24
h) with pcDNA3.1/GFP or co-transfected with pcDNA3.1/
GFP and sense CLC-5/antisense CLC-5 using a Ag ratio of
3:1 and cells were overlaid with 500 Al of calcium phos-
phate solution for 30 min at 37 jC.
COM crystals were prepared as described by Lieske et al.
[31] by vapour diffusion from diethyloxalate into calcium-
containing buffer (155 mM NaCl, 5.4 mM KCl, 100 mM
glucose, 50 mM CaCl2, 90 mM Tris). Rather than culture
cells in the presence of diethyloxalate vapour, as we have
previously shown [10], 200 Al aliquots of the resulting
COM crystals were removed and used to overlay sub-
confluent transiently transfected cells (in a directly compa-
rable way to that of calcium phosphate crystals) and
incubated for 30 min.
Coverslips were imaged by CLSM (Leica TCS-NT)
using FITC and transmitted light filter sets with a  100
oil immersion lens (NA 1.4) to allow optical sectioning. z-
series images were collected and merged using Adobe
PhotoShop software. Positive transfectants were examined
and analysed in a blinded fashion. Cell surface crystal
attachments were measured by analysis of transmitted light
z-series images, allowing the maximum diameter of crystal
attachment to be calculated. Crystal attachment measuring
>10 Am were considered to be a crystal agglomeration.
To control for transfection-induced toxicity, transfected
cells were assayed with ‘Live/Dead Cytotoxicity Kit’ (Mo-
lecular Probes) using colocalisation of DEAD Red ethidium
homodimer-2 nuclear stain and GFP. Transfection with
CLC-5 and GFP cDNA constructs did not increase cell
staining compared to untransfected controls.
In separate experiments, CLC-5-GFP-transfected cells
were overlaid with calcium phosphate and calcium oxalate
crystals (prepared as above) before imaging and analysis as
described above.
2.6. Statistics
For comparisons of size of crystal attachments and
agglomerations between sense- and antisense-treated cells,
the Chi-square test was used.3. Results and discussion
3.1. CLC-5 protein expression and reduction of CLC-5
protein following antisense CLC-5 transfection
Fig. 1 confirms endogenous CLC-5 expression in whole
kidney and mIMCD-3 cells. A band of 83 kDa as predicted
for CLC-5, is readily detected in murine whole kidney (Fig.
1A, lane 1). Two additional bands are seen, a diffuse f 90
kDa band and a faint high molecular weight band,corresponding to f 166 kDa. The relative intensity of the
high molecular weight band to that at f 83 kDa remained
unchanged after gel electrophoresis was repeated in non-
reducing conditions (data not shown). With mIMCD-3
protein, a prominent band is present at f 166 kDa (Fig.
1A, lane 2) in addition to a number of faint bands between
83 and 166 kDa. Preabsorption of PEP5A1 antibody with
peptide (CKSRDRDRHREITNKS-amide) resulted in disap-
pearance of the prominent 83 kDa band in whole kidney and
the 166 kDa band in mIMCD-3 protein (Fig. 1A, lanes 3
and 4). More stringent reducing conditions applied to
mIMCD-3 protein failed to remove the 166 kDa band in
favour of 83 kDa (not shown). Given the specificity of the
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in dimeric form in mIMCD-3 cells. Diffuse 83 kDa bands
with high molecular components have previously been
shown, but not discussed, using comparable and different
anti-CLC-5 antibodies [32,33] in Western blots for CLC-5
protein. The crystal structure of the CLC family, confirmed
in two bacterial CLCs elucidated to 3 A˚, indicates a two-
pore homodimer [15]. The demonstration by Western blot
analysis of expression of mostly CLC-5 monomer in whole
kidney and almost exclusively dimer in mIMCD-3 cells isFig. 2. Antisense CLC-5 transfection causes calcium phosphate crystal agglom
pcDNA3.1/GFP alone, (B) co-transfected with pcDNA3.1/GFP and sense CLC-5
overlaid with calcium phosphate crystals. Scale bar = 10 Am. Quantification of cr
treated cells. Data shown are from six separate experiments. Control and sense CL
attachments (up to 10 Am in diameter). The remaining control and sense CLC-5 ce
For antisense CLC-5 transfectants, the majority of cells (21/32, P < 0.001) were asinteresting. mIMCD-3 cells are a distinct cell population
derived from the terminal portion of murine collecting duct
[27] accounting for only a small fraction of renal mass as
opposed to the heterogeneous mix of cells constituting
whole kidney, and this may account for the observed
difference in expression. Certainly the dimeric form of
CLC-5 was resistant to reduction, implying a highly stable
quaternary structure. We speculate that the difference in
ratios of monomeric form to dimeric form in renal tissue
may be an indication of rapid turnover of CLC-5 withineration. Comparison of mIMCD-3 cells transiently transfected with (A)
, and (C) co-transfected with pcDNA3.1/GFP and antisense CLC-5 when
ystal attachment in (D) control (E) sense CLC-5 (F) and antisense CLC-5
C-5 transfectants demonstrated either no crystal attachment or small crystal
lls (2/23, 4/31) showed adhesion of larger (11–50 Am) crystal agglomerates.
sociated with crystal agglomerates (>10 Am). (For color see online version).
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available within the biosynthetic pathway to form into
dimers necessary for specific function.
Fig. 1B shows that transient transfection with antisense
CLC-5 plasmid results in a f 50% reduction in the density
of the mCLC-5 specific f 166 kDa band compared to
control and sense CLC-5 treated cells (relative intensities:
1.0, 0.9, 0.5 arbitrary units, respectively). This provides
confirmatory evidence as to the identity of the f 166 kDa
band. This Western blot evidence of knock-down of CLC-5Fig. 3. Antisense CLC-5 transfection causes calcium oxalate crystal agglomeration
GFP alone, (B) co-transfected with pcDNA3.1/GFP and sense CLC-5, and (C) co
calcium oxalate crystals. Scale bar = 10 Am. Quantification of crystal attachment i
shown are from five separate experiments. In the majority of control and sense CL
was observed. For antisense mCLC-5 transfectants 50 cells were analysed. The ma
(>10 Am). (For color see online version).protein is consistent with our previous data, where we
demonstrate by immunocytochemistry that transient trans-
fection of antisense CLC-5 reduces intracellular expression
of CLC-5 in mIMCD-3 cells [10].
3.2. Antisense CLC-5 transfectants result in agglomeration
of calcium phosphate and oxalate crystals
Since crystal attachment and internalisation may repre-
sent an intrinsic mechanism for prevention of stone forma-. Comparison of mIMCD-3 cells transiently transfected with (A) pcDNA3.1/
-transfected with pcDNA3.1/GFP and antisense CLC-5 when overlaid with
n control (D) sense CLC-5 (E) and antisense CLC-5 (F) treated cells. Data
C-5 transfectants (34/44 and 38/44 cells, respectively) no crystal attachment
jority of cells (33/50, P< 0.0001) were associated with crystal agglomerates
Fig. 4. Calcium phosphate and calcium oxalate crystals are internalised by
mIMCD-3 cells and are associated with CLC-5. mIMCD-3 cells co-
transfected with sense CLC-5 and pcDNA3.1/GFP were overlaid with
(A–C) calcium phosphate or (E–G) calcium oxalate crystals. Positive
transfectants were identified by their green fluorescence (not shown).
Evidence of crystal internalisation within transfectants (thin arrows) is
seen from xy-sections taken at the (A, E) top, (B, F) middle and (C, G)
base of the cells. mIMCD-3 cells transiently transfected with CLC-5-GFP
were overlaid with (D) calcium phosphate and (H) calcium oxalate
crystals. Images shown represent mid-cell xy-sections. GFP tagged CLC-5
is seen surrounding internalised small crystals (thick arrows). Scale
bar = 10 Am.
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to pre-formed calcium phosphate and calcium oxalate
crystals.
For cells exposed to calcium phosphate, both pcDNA3.1/
GFP control transfectants and those co-transfected with
pcDNA3.1/GFP and sense CLC-5 were comparable (Fig.
2A,B). These cells had predominantly an absence of crystals
(10/23 and 13/31, respectively) or single small crystal
attachments up to 10 Am in diameter (11/23 and 14/31
cells, respectively). Larger crystals (11–50 Am) were seen in
2/23 and 4/31 cells, respectively (Fig. 2D,E).
In contrast, pcDNA3.1/GFP and antisense CLC-5 co-
transfectants demonstrated a marked increase (21/32 cells,
P < 0.001) in the tendency to form large (>10 Am) crystal
agglomerations (Fig. 2C,F) when compared to control or
sense transfectants. There was also a corresponding fall in
the number of cells having single crystal attachments (2/32
cells) (Fig. 2F).
For cells overlaid with calcium oxalate, control and sense
CLC-5-transfected cells behaved similarly (Fig. 3A,B), with
either absence of crystals (34/44 and 38/44 cells, respec-
tively) or limited small single crystal attachment (5/44 and
2/44 cells, respectively) (Fig. 3D,E). Crystal agglomerations
greater than 10 Am were rarely observed (5/44 and 4/44
cells, respectively). After antisense mCLC-5 transfection,
the majority of antisense CLC-5 transfectants (33/50,
P < 0.0001) were associated with crystal agglomerations at
the cell surface (Fig. 3C,F).
Adherence of small calcium phosphate and calcium
oxalate crystals often appeared to be accompanied by rapid
crystal endocytosis. Of the 14 sense CLC-5-transfected
cells associated with calcium phosphate crystals less than
10 Am in diameter (Fig. 2E), in 11 showed evidence of
crystal internalisation. When the focal plane was at a mid or
base section, small crystals were visualised but when the
focal plane was at the cell surface, crystals were not evident
(Fig. 4A–C). This finding of small crystal internalisation
was confirmed by the use of CLC-5-GFP constructs, where
mid-cell xy-sections demonstrate internalisation of small
calcium phosphate crystals associated with CLC-5, which
appears to surround the crystal (Fig. 4D). In the calcium
oxalate experiments, small crystals less than 10 Am in
diameter were less frequently seen associated with sense
CLC-5 transfectants. Only two cells had this finding (Fig.
3E), but analysis of these cells revealed that in each case,
there was evidence of crystal internalisation from the
surface to within the cell (Fig. 4E–G). CLC-5-GFP also
appeared to surround these internalised calcium oxalate
crystals (Fig. 4H).
These data demonstrate that both calcium phosphate
(hydroxyapatite) and calcium oxalate (COM) crystals may
attach and be endocytosed from the surface of mIMCD-3
cells. Although the crystal attachment experiments were
performed in sub-confluent cells, which have been shown
to be more susceptible to crystal binding [34], we have
confirmed that both calcium phosphate and calcium oxalatecrystal attachment and internalisation also occurs when
these cells were grown to confluency (data not shown).
mIMCD-3 cells behave, in terms of crystal adherence, in a
similar manner to the LLC-PK1 cell line [35,36]. It is of
note that the RCCD1 and MDCK-I cell lines with distal and
collecting duct phenotype failed to endocytose calcium
oxalate crystals [36], confirming this process is likely to
depend upon specific cell receptors and is not uniform along
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isation are thus complex and it is also likely that specific
crystal species will be handled differently.
Recent data suggests that calcium phosphate crystals may
be the initiating event of both interstitial calcification and
intratubular calcium oxalate stone formation [26]. Patients
with idiopathic calcium oxalate stone formation developed
interstitial crystal deposits, which led to calcium apatite
plaque formation [26]. Subsequent penetration of this
plaque would provide a surface for calcium oxalate adhe-
sion and stone formation. Examination of histological
section of collecting ducts in hyperoxaluric patients (sec-
ondary to intestinal bypass surgery) revealed apical attach-
ment of calcium apatite crystals, which led to intraluminal
obstruction and epithelial damage [26].
The crystal–epithelial cell interaction appears dramatical-
ly different in CLC-5 knockdown cells, compared to cells
expressing wild-type CLC-5. Both calcium phosphate and
calcium oxalate crystals more readily adhere to the CLC-5
knockout cells, which then appear to act as a nucleus for
crystal agglomeration. This process is relatively rapid and it is
likely that either CLC-5 knockdown cells are expressing
increased levels of crystal adhesion molecules, decreased
levels of crystal inhibitors or are unable to process and
dissolve (by endocytosis) such large adherent crystals. Sev-
eral recent studies suggest that calcium microcrystals bind to
specific receptors on the cell surface [5,31,36–38]. It is of
note that annexin II, a COM binding protein, colocalises with
caveolin-I and is involved in exocytosis and endocytosis
pathways. It now needs to be determined whether CLC-5 is
regulating plasma membrane expression of such adhesion
molecules. In cells deficient in CLC-5, we speculate that
inhibition of endocytosis and of traffic or recycling of early
endosomes alters the apical membrane complement of sur-
face proteins and of secreted molecules regulating crystal
adherence, e.g. osteopontin [39], hyaluronan [38,40] and
annexin II [37]. This would then lead to the increased binding
and attachment of initial calcium microcrystals. It is also
possible that antisense CLC-5 transfection may induce a
degree of endoplasmic reticulum stress, secondary to accu-
mulation of misfolded proteins, thereby promoting the ex-
pression of hyaluronan [41]. This glycosaminoglycan would
then promote crystal interactions at the plasma membrane.
Inhibition of endocytosis, as previously demonstrated in
CLC-5-deficient cells [10] may also lead to prolonged
retention time of crystals at the epithelial surface, allowing
enhanced agglomeration of crystals. Direct cytotoxicity of
the antisense cDNA transfection was excluded prior to crystal
adhesion by measurements of ethidium bromide homodimer-
2 (Dead Red) in positive transfectants. We are unable,
however, to dismiss the possibility that increased crystal
attachment and agglomeration would result in downstream
cell signalling leading to cell activation and further crystal
deposition. COM crystal attachment is known to stimulate
down-stream signalling events including p38 MAP kinase
activation in LLCPK1 cells [42]. Clearly, a key feature is theincreased residence time of COM crystal on the apical
surface. This then acts as a nucleus for further crystal
adhesion, which as these data show, occurs much more
readily in CLC-5-deficient cells.
We conclude that an endocytic role for CLC-5 in the
collecting duct and disrupted cellular handling of calcium
crystals may account for the unexplained phenotype of
nephrocalcinosis and renal stone formation in Dent’s disease.Acknowledgements
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